๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate

โœ Scribed by S.R. Marder; M. Aravagiri; W.C. Wirshing; D.A. Wirshing; M. Lebell; J. Mintz

Book ID
119553825
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
68 KB
Volume
53
Category
Article
ISSN
0920-9964

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Fluphenazine plasma levels in patients r
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoate
โœ Stephen R. Marder; Edward M. Hawes; Theodore Putten; John W. Hubbard; Gordon McK ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 487 KB

Plasma fluphenazine concentrations (FLU) were measured in 45 patients with schizophrenic disorders who participated in a double-blind comparison of 5 and 25 mg fluphenazine decanoate (FD). The rise in plasma level of FLU 24 h after a "test dose" was significantly correlated with steady state FLU con

Plasma fluphenazine concentrations in ou
Plasma fluphenazine concentrations in outpatients receiving fluphenazine decanoate (Modecate)
โœ Nigel M. Kimber; Peter F. Marriott; Trevor R. Norman; Graham D. Burrows ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 394 KB

Plasma fluphenazine concentrations were measured by neuroleptic radioreceptor assay in 17 outpatients receiving chronic treatment with intramuscular fluphenazine decanoate. The range of concentrations was 0.5-2.4 pglL over the dosage range of 0.30-3.2 mg/d. Age, sex and smoking status had no influen